Artificial Intelligence in Medical Diagnostics Market Worth $9.38 Billion by 2029

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User (Hospital, Diagnostic Center) – Global Forecast to 2029

The Artificial Intelligence in Medical Diagnostics Market is expected to reach $9.38 billion by 2029, at a CAGR of 36.2% from 2022 to 2029. Artificial intelligence (AI) in medical diagnostics is a powerful tool that has the potential to make healthcare more accessible and affordable by assisting healthcare providers in making accurate and quick treatment decisions for their patients. The accurate diagnosis of a disease takes years of medical training and is a time-consuming process. The use of AI in medical diagnosis has proven to give accurate diagnoses, aid in clinical decisions, and enhance physicians' judgment.

AI in medical diagnostics includes AI solutions that aid physicians with medical decision-making. AI-based solutions can be used to diagnose cancer, triage critical findings in medical imaging, flag acute abnormalities, help radiologists prioritize life-threatening cases, diagnose cardiac arrhythmias, predict stroke outcomes, and help with the management of chronic diseases.

The growth of this market is driven by the growing need for the adoption of AI in medical diagnosis to reduce errors, the shortage of healthcare professionals, and the rising incidence rate of chronic diseases. In addition, the growth potential in emerging economies and the growing number of cross-industry partnerships & collaborations are expected to provide significant growth opportunities for this market.